S64315

S64315 · Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S64315, covering 2024-06-06 to 2024-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia [Phase 1, Phase 2]